Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
about
Fish Peroxiredoxins and Their Role in ImmunityPeroxiredoxin 1 - an antioxidant enzyme in cancerHuman peroxiredoxin 1 and 2 are not duplicate proteins: the unique presence of CYS83 in Prx1 underscores the structural and functional differences between Prx1 and Prx2Cysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent SecretionThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingPeroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculatureDevelopment of a multiplex autoantibody test for detection of lung cancerMitochondrial peroxiredoxin III is a potential target for cancer therapyRedox proteomics of the inflammatory secretome identifies a common set of redoxins and other glutathionylated proteins released in inflammation, influenza virus infection and oxidative stress.Peroxiredoxin I regulates the component expression of γ-secretase complex causing the Alzheimer's disease.Expression and prognostic significance of human peroxiredoxin isoforms in endometrial cancerOxidation state governs structural transitions in peroxiredoxin II that correlate with cell cycle arrest and recovery.Proteomic analysis of naturally-sourced biological scaffolds.Immunoproteomic identification of bovine pericardium xenoantigensPeroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approachProteomic analysis of non-small cell lung cancer tissue interstitial fluids.Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinomaHelminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.Cell stress proteins in atherothrombosisSecretome Analysis of Skeletal Myogenesis Using SILAC and Shotgun Proteomics.Elevated prx1 provides resistance to docetaxel, but is not associated with predictive significance in lung cancerProteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.Redox Regulation of Inflammatory Processes Is Enzymatically Controlled.THE MULTI-FACETED IMPACT OF PEROXIREDOXINS ON AGING AND DISEASE.Peroxiredoxin-1 promotes cell proliferation and metastasis through enhancing Akt/mTOR in human osteosarcoma cells.Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica.Copeptin and Peroxiredoxin-4 Independently Predict Mortality in Patients With Nonspecific Complaints Presenting to the Emergency Department
P2860
Q26774985-CB1A0DC6-8F09-41B1-87F0-91E6079D79B7Q28070359-EA652F1A-665B-4D22-ACE0-DF62BDF87132Q28118786-DE681E49-0150-4C28-B3D4-C65346FBF8D2Q28257763-93CD2FF4-6AF6-4EEE-9301-69E2F423DE61Q28389739-9F248239-595D-49CD-BE64-73FDB808FA08Q34204503-B1522242-2CEE-44E2-B842-FA5894438AE7Q34347517-0AF659CE-CB7C-4FBF-9A6F-3D3459CDB3A4Q34793013-38A3CD3B-AFB0-4329-B0E0-E680192115CAQ35154906-1B33A3C9-1784-463F-B953-9E5941E2B347Q35536098-D9FB1B64-4849-42DA-BD11-13DDB80693B9Q35634273-6028115A-0745-4481-A70E-C82BC9FBF1E3Q35653389-E0A202DD-24B3-4BE7-9EC5-E54473160F51Q36084300-2A31A45F-E872-41E2-BCC3-DE9188133F0DQ36119402-9E680157-EAAA-4C88-9985-AF40BC1DBE1CQ36278956-EB3DC8AA-7495-40EF-AADB-16AF8355A3B7Q36841930-DC1FE11C-7285-4037-96CF-1874EAB1D52DQ36865282-914F365B-0380-41F3-9EBE-9CCFF3DC9CA8Q37116256-B7832962-E01C-4F81-8991-ABE44E531B57Q37119458-2FB9B117-AC15-4571-9A2D-7A26CE6827D2Q37288443-77F55873-3E81-4C5E-88AD-F453BDC4EBA6Q37693527-0621708B-0812-4F16-86D9-609EABAA5092Q37997003-3D5B8BC1-550C-4DCD-96C5-48E161FD1CDAQ38026043-E687FB58-CA39-4E76-8C7D-FC79641DC504Q38805063-3B689B54-888F-495B-A47E-6C66BCD32065Q41773604-8DD3B5A8-E8B1-4333-89BB-7ECBD6765841Q43784891-0AEC5B35-5DB2-4E80-844A-20CEF13B94BFQ45338276-752B71C3-F9E6-4388-9DC0-7FBCF9A37CC9Q46246645-F021BC00-0BD5-405A-93EB-736977D264BBQ52680492-4B36968E-5948-46B6-9465-1CDC4A65E61EQ54456888-14CE0324-0099-4D91-9D5F-77ECB201B8CCQ57759242-2985BBF7-E7DE-491D-97CF-CA0B07D89EE7
P2860
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@ast
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@en
type
label
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@ast
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@en
prefLabel
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@ast
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@en
P2093
P2860
P1433
P1476
Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer.
@en
P2093
Ho Zoon Chae
Jong Wook Chang
Ju Yeon Jeong
Seung Hee Lee
Young Chul Kim
Yung Joon Yoo
Zee-Yong Park
P2860
P304
P356
10.1016/J.FEBSLET.2005.04.028
P407
P577
2005-05-01T00:00:00Z